Profile
Jorge DiMartino is currently a Director at Gotham Therapeutics Corp.
Prior to this, he was the Chief Medical Officer & EVP-Clinical Development at Kronos Bio, Inc. from 2019 to 2024.
Before that, he served as Vice President-Translational Development Oncology at Celgene Corp.
from 2014 to 2019.
He also worked as a Group Medical Director at Genentech, Inc. Additionally, he holds a doctorate degree from both the University of California San Diego and Cornell University Graduate School.
Jorge DiMartino active positions
| Companies | Position | Start |
|---|---|---|
Gotham Therapeutics Corp.
Gotham Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical medicines | Director/Board Member | - |
Former positions of Jorge DiMartino
| Companies | Position | End |
|---|---|---|
| KRONOS BIO, INC. | Chief Tech/Sci/R&D Officer | 16/02/2024 |
| CELGENE | Corporate Officer/Principal | 01/12/2019 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Chief Tech/Sci/R&D Officer | - |
Training of Jorge DiMartino
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cornell University Graduate School
Cornell University Graduate School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kronos Bio, Inc.
Kronos Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel cancer therapeutics | Health Technology |
Gotham Therapeutics Corp.
Gotham Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical medicines | Health Technology |
- Stock Market
- Insiders
- Jorge DiMartino
















